Statement of Organization, Functions, and Delegations of Authority, 38819-38821 [2010-16101]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 128 / Tuesday, July 6, 2010 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, (301) 594–
6377, sigmonh@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 29, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
AGENCY: Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of request for
nominations for public members.
SUMMARY: Section 921 (now Section 941
of the Public Health Service Act (PHS
Act)), 42 U.S.C. 299c, established a
National Advisory Council for
Healthcare Research and Quality (the
Council). The Council is to advise the
Secretary of HHS (Secretary) and the
Director of the Agency for Healthcare
Research and Quality (AHRQ) on
activities proposed or undertaken to
carry out the agency mission including
providing guidance on (A) Priorities for
health care research, (B) the field of
health care research including training
needs and information dissemination on
health care quality and (C) the role of
the Agency in light of private sector
activity and opportunities for public
private partnerships.
Seven current members’ terms will
expire in November 2010. To fill these
positions in accordance with the
legislative mandate establishing the
Council, we are seeking individuals
who are distinguished: (1) In the
conduct of research, demonstration
projects, and evaluations with respect to
health care; (2) in the fields of health
care quality research or health care
improvement; (3) in the practice of
medicine; (4) in other health
professions; (5) in the fields of health
care economics, information systems,
law, ethics, business, or public policy;
and (6) individuals who could represent
the interests of patients and consumers
Jkt 220001
Section
941 of the PHS Act, 42 U.S.C. 299c,
provides that the Secretary shall appoint
to the National Advisory council for
Healthcare Research and Quality twenty
one appropriately qualified individuals
and specifies that at least seventeen
members shall be representatives of the
public and at least one member shall be
a specialist in the rural aspects of one
or more of the professions or fields
listed in the above summary. In
addition, the Secretary is directed to
designate, as ex officio members,
representatives from Federal agencies
specified in the authorizing legislation,
principally agencies that conduct or
support health care research, as well as
other Federal officials the Secretary may
consider appropriate. The Council
meets in the Washington, DC,
metropolitan area, generally in
Rockville, Maryland, approximately
three times a year to provide broad
guidance to the Secretary and AHRQ’s
Director, as described above, on the
direction of and programs undertaken
by AHRQ.
Seven individuals will be selected
presently by the Secretary to serve on
the Council beginning with the meeting
in the spring of 2011. Members
generally serve 3-year terms.
Appointments are staggered to permit
an orderly rotation of membership.
Interested persons may nominate one
or more qualified persons for
membership on the Council. Selfnominations are accepted. Nominations
shall include: (1) A copy of the
nominee’s resume or curriculum vitae;
and (2) a statement that the nominee is
willing to serve as a member of the
Council. Selected candidates will be
asked to provide detailed information
concerning their financial interests,
SUPPLEMENTARY INFORMATION:
National Advisory Council for
Healthcare Research and Quality:
Request for Nominations for Public
Members
14:52 Jul 02, 2010
Nominations should be sent
to Ms. Karen Brooks, AHRQ, 540
Gaither Road, Room 3006, Rockville,
Maryland 20850. Nominations may also
be e-mailed to mailto: AHRQ National
Advisory Council@AHRQ.hhs.gov or
faxed to (301) 427–1201.
FOR FURTHER INFORMATION CONTACT: Ms.
Karen Brooks, AHRQ, at (301) 427–
1801.
ADDRESSES:
[FR Doc. 2010–16334 Filed 7–2–10; 8:45 am]
VerDate Mar<15>2010
of health care; and (7) the private health
care sector (including health plans,
providers, and purchasers) possibly
including distinguished administrators
of health care delivery systems.,
Individuals are particularly sought with
experience and success in activities
specified in the summary above.
DATES: Nominations should be received
on or before 60 days after date of
publication.
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
38819
consultant positions and research grants
and contracts, to permit evaluation of
possible sources of conflict of interest.
Please note that once you are
nominated, AHRQ may consider your
nomination for future positions on the
Council. In accordance with a
Memorandum from the President dated
June 18, 2010, Federally registered
lobbyists are not eligible for positions
on Federal advisory councils.
The Department seeks broad and
diverse geographic representation on the
Council. In addition, since AHRQ is
mandated to conduct and support
research concerning priority
populations, which under 42 U.S.C.
299(c) includes: Low-income groups;
minority groups; women; children; the
elderly; and individuals with special
health care needs, including individuals
with disabilities and individuals who
need chronic care or end-of-life health
care, nominations of individuals with
expertise in health care for these
priority populations are encouraged.
Dated: June 25, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–16102 Filed 7–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 75 FR 22821–29, dated
April 30, 2010) is amended to reflect the
reorganization of the Division of Blood
Disorders within the National Center on
Birth Defects and Developmental
Disabilities, Office of Noncommunicable
Diseases, Injury and Environmental
Health, Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statement for the Office of the
Director (CUBD1) and insert the
following.
Office of the Director (CUBD1). (1)
Provides leadership and guidance on
strategic planning and implementation,
E:\FR\FM\06JYN1.SGM
06JYN1
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
38820
Federal Register / Vol. 75, No. 128 / Tuesday, July 6, 2010 / Notices
program priority setting, and policy
development, to advance the mission of
the Division of Blood Disorders,
NCBDDD and CDC; (2) develops goals,
objectives, and budget; monitors
progress and allocation of resources,
and reports accomplishments, future
directions, and resource requirements;
(3) facilitates scientific, policy and
program collaboration among divisions
and centers, and between CDC and other
Federal/non-Federal partners; (4)
promotes advancement of science
throughout the division, supports
program evaluation, and ensures that
research meets the highest standards in
the field; (5) provides medical expertise
and consultation to planning, projects,
policies and program activities; (6)
advises the Office of the Director of
NCBDDD on matters relating to
prevention of complications due to
blood disorders and coordinates
division responses to requests for
technical assistance or information on
activities supported by the division; (7)
develops and produces communications
tools and public affairs strategies to
meet the needs of division programs and
mission; (8) represents the division at
official professional and scientific
meetings, both within and outside of
CDC; (9) applies evaluation and
prevention effectiveness functions in
the assessment of blood disorder
programs, projects and activities; (10)
develops, implements and evaluates
long term plans for surveillance,
research and prevention activities
pertaining to blood disorders; and (11)
drafts and disseminates reports of future
plans and needs to inform policy.
After the Office of the Director
(CUBD1) Division of Blood Disorders,
National Center on Birth Defects and
Developmental Disabilities, Office of
Noncommunicable Diseases, Injury and
Environmental Health, Centers for
Disease Control and Prevention, insert
the following:
Epidemiology and Surveillance
Branch (CUBDB). (1) Provides scientific
leadership in the design and
implementation of monitoring systems
as well as designs and conducts
epidemiologic and genetic research to
identify causes, risk factors and
complications of blood disorders in
affected populations; (2) designs and
manages surveillance systems to
evaluate the incidence, morbidity, and
mortality associated with blood diseases
and disorders; (3) plans, develops and
coordinates special surveys and
populations studies to monitor and
assess the complications of blood
disorders; (4) designs and implements
studies using surveillance data to
identify risk factors for the
VerDate Mar<15>2010
14:52 Jul 02, 2010
Jkt 220001
complications of blood disorders, and
evaluates the effectiveness of the
prevention activities; (5) provides
epidemiologic and medical consultation
and technical assistance, including
epidemic aids to State and local health
departments, other governmental
agencies, and other public and private
institutions in the investigation of blood
disorders and related complications; (6)
designs and implements studies to
evaluate the effectiveness of
implemented prevention strategies in
the treatment centers; (7) works closely
with internal and external organizations
in applying prevalence and incidence
data to target and evaluate programs to
prevent the complications of blood
diseases and chronic hereditary
disorders; (8) publishes findings and
advances arising out of surveillance and
epidemiologic research to the scientific
and public health communities; (9)
provides training services to States,
localities, and other countries in
investigation, diagnosis, prevention, and
control of blood diseases and chronic
hereditary disorders; (10) assists in
designing, implementing, and
evaluating prevention and counseling
programs for persons and their families
with chronic blood diseases and
selected chronic hereditary disorders;
(11) designs, implements and
coordinates the prevention and
surveillance activities of specialized
Federally funded prevention centers
organized to prevent the complications
of blood diseases and chronic hereditary
disorders; (12) conducts and supports
both qualitative and quantitative
research to expand the knowledge base
related to blood disorders across the
lifespan; and (13) collaborates with
laboratory research branch and
prevention research branch and
incorporates the findings of these
branches’ activities which leads to
prevention of complications of blood
disorders.
Laboratory Research Branch
(CUBDC). (1) Identifies new genetic
markers of risk factors and clotting
defects for affected groups; (2) provides
reference laboratory diagnosis for multisite epidemiologic and surveillance
studies; (3) develops techniques and
interpretation methods to improve
molecular and coagulation diagnosis; (4)
provides diagnostic support for
epidemiologic studies and epidemic
aids on emerging blood disorders and
chronic hereditary disorders; (5)
determines the mechanisms of
pathogenesis and complications of
blood disorders and chronic hereditary
disorders; (6) conducts research and
provides reference services on
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
diagnostic techniques for blood
disorders and chronic hereditary
disorders; (7) conducts research to
improve laboratory methodologies and
materials; (8) where appropriate,
maintains the national reference
laboratory for blood disorders and
chronic hereditary disorders; (9) works
closely with entities and organizations
within the agency and organizations
external to the agency to provide
laboratory services in support of
projects whose primary aim is to
prevent and reduce complications
associated with blood disorders and
chronic hereditary disorders; and (10)
publishes findings and advances arising
out of surveillance and epidemiologic
research to the scientific and public
health communities.
Prevention Research and Informatics
Branch (CUBDD). (1) Performs health
services research; (2) translates and
evaluates the latest scientific advances
from surveillance, epidemiology and
laboratory support into enhanced
delivery of care, prevention services,
and information for affected
populations; (3) develops, implements,
evaluates and disseminates education
and communication interventions that
seek to identify and educate affected
populations, providers and the public
on health risks, protective factors and
measures of effectiveness of health
promotion activities and prevention of
complications related to blood
disorders; (4) collects, analyzes and
prepares reports to document the
prevalence and incidence of blood
disorders and related complications and
provides this information to affected
populations through reports,
publications, and public access data
sets; (5) supports public health analysis
to include facilitating data collection,
data management, data manipulation,
analysis, project reporting and
presentation; (6) coordinates
partnership activities; (7) assesses
informatics needs and develops
strategies to ensure accurate collection
of data related to blood disorders and
the division’s activities; (8) conducts
applied research to develop, evaluate,
improve and standardize public
information systems and educational
modules which support the prevention
of complications from blood disorders;
(9) develops and maintains systems for
collection, processing, validation,
storage and dissemination of the highest
quality information to study and
monitor blood disorders; (10)
disseminates findings and advances
arising out of surveillance and
epidemiologic research to the scientific
and public health communities, and the
E:\FR\FM\06JYN1.SGM
06JYN1
Federal Register / Vol. 75, No. 128 / Tuesday, July 6, 2010 / Notices
general public; (11) collaborates with
and provides technical assistance,
consultation, and training to local, State,
Federal, and international agencies,
universities and governmental and nongovernmental organizations on blood
disorders and health related issues; (12)
collaborates with local, State, Federal,
and international agencies, and
appropriate governmental and nongovernmental organizations to develop,
review, and implement policies that
advance the health of people with blood
disorders across the lifespan; (13)
collaborates with funded nongovernmental agencies to disseminate
best practices, identify areas of need,
facilitate development and distribution
of educational materials, and provide
informational resources to States and
affected populations and their
caregivers; and (14) develops
informatics related trainings and
communicates informatics changes to
external partners.
Dated: June 21, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–16101 Filed 7–2–10; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HOMELAND
SECURITY
[DHS Docket No. DHS–2009–0032]
Office for Civil Rights and Civil
Liberties: Guidance to Federal
Financial Assistance Recipients
Regarding Title VI Prohibition Against
National Origin Discrimination
Affecting Limited English Proficient
Persons
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
AGENCY: Office for Civil Rights and Civil
Liberties, DHS.
ACTION: Notice; extension of comment
period to July 17, 2010.
SUMMARY: The Department of Homeland
Security is extending the public
comment period until July 17, 2010, for
proposed guidance to recipients of
Federal financial assistance regarding
Title VI’s prohibition against national
origin discrimination affecting limited
English proficient persons. This
proposed guidance is issued pursuant to
Executive Order 13166 and is consistent
with government-wide guidance
previously issued by the Department of
Justice.
DATES: Written comments are invited
from interested persons and
organizations no later than July 17,
2010.
VerDate Mar<15>2010
14:52 Jul 02, 2010
Jkt 220001
Comments should be sent
to:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Officer for Civil Rights and
Civil Liberties, U.S. Department of
Homeland Security, 245 Murray Lane,
SW., Building 410, Washington, DC
20528, Mail Stop 0190. To ensure
proper handling, please reference DHS
Docket No. DHS–2009–0032 on the
correspondence. This mailing address
may also be used for paper, disk, or CD–
ROM submissions. DHS will accept
comments in alternate formats such as
Braille, audiotape, etc. by mail.
• E-Mail: crcl@dhs.gov. The subject
line should include ‘‘LEP Docket DHS–
2009–0032.’’
• TTY: 202–401–0470, Toll Free TTY:
1–866–644–8361. TTY callers may also
contact us through the Federal Relay
Service TTY at (800) 877–8339. Other
Federal Relay Service options are
available at www.gsa.gov/fedrelay.
• Facsimile: (202) 401–4708 (not a
toll-free number).
Instructions for filing comments: All
submissions received must include the
agency name and DHS docket number
DHS–2009–0032. All comments
received (including any personal
information provided) will be posted
without change to https://
www.regulations.gov.
Reviewing comments: Public
comments may be viewed online at
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Rebekah Tosado, Senior Advisor to the
Officer for Civil Rights and Civil
Liberties, Office for Civil Rights and
Civil Liberties, Department of Homeland
Security, 245 Murray Lane, SW.,
Building 410, Washington, DC 20528,
Mail Stop 0190. Toll free: 1–866–644–
8360 or TTY 1–866–644–8361. Local:
202–401–1474 or TTY: 202–401–0470.
SUPPLEMENTARY INFORMATION: The
Department of Homeland Security
issued proposed guidance on June 17,
2010, for recipients of Federal financial
assistance regarding Title VI’s
prohibition against national origin
discrimination affecting limited English
proficient persons. 75 FR 34465. Due to
inadvertence, the date specified for
receipt of comments did not permit a
full 30 day comment period.
Accordingly, the Department of
Homeland Security is extending the
comment period to July 17, 2010.
ADDRESSES:
Margo Schlanger,
Officer for Civil Rights and Civil Liberties.
[FR Doc. 2010–16362 Filed 7–2–10; 8:45 am]
BILLING CODE 9110–9B–P
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
38821
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Agency Information Collection
Activities: Application—Alternative
Inspection Services (SENTRI
Application and FAST Commercial
Driver Application)
AGENCY: U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: 60-Day Notice and request for
comments; Extension of an existing
collection of information: 1651–0121.
SUMMARY: As part of its continuing effort
to reduce paperwork and respondent
burden, U.S. Customs and Border (CBP)
invites the general public and other
Federal agencies to comment on an
information collection requirement
concerning the Application—
Alternative Inspection Services
including the SENTRI Application (CBP
Form 823S) and the FAST Commercial
Driver Application (CBP Form 823F).
This request for comment is being made
pursuant to the Paperwork Reduction
Act of 1995 (Pub. L. 104–13; 44 U.S.C.
3506(c)(2)(A)).
DATES: Written comments should be
received on or before September 7,
2010, to be assured of consideration.
ADDRESSES: Direct all written comments
to U.S. Customs and Border Protection,
Attn.: Tracey Denning, U.S. Customs
and Border Protection, Office of
Regulations and Rulings, 799 9th Street,
NW., 7th Floor, Washington, DC 20229–
1177.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to U.S. Customs and
Border Protection, Attn.: Tracey
Denning, U.S. Customs and Border
Protection, Office of Regulations and
Rulings, 799 9th Street, NW., 7th Floor,
Washington, DC 20229–1177, at 202–
325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L.104–13;
44 U.S.C. 3506(c)(2)(A)). The comments
should address the accuracy of the
burden estimates and ways to minimize
the burden including the use of
automated collection techniques or the
use of other forms of information
technology, as well as other relevant
aspects of the information collection.
The comments that are submitted will
be summarized and included in the CBP
request for Office of Management and
E:\FR\FM\06JYN1.SGM
06JYN1
]]>Agencies
[Federal Register Volume 75, Number 128 (Tuesday, July 6, 2010)]
[Notices]
[Pages 38819-38821]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-16101]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 75 FR 22821-29, dated April 30, 2010) is
amended to reflect the reorganization of the Division of Blood
Disorders within the National Center on Birth Defects and Developmental
Disabilities, Office of Noncommunicable Diseases, Injury and
Environmental Health, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statement for the
Office of the Director (CUBD1) and insert the following.
Office of the Director (CUBD1). (1) Provides leadership and
guidance on strategic planning and implementation,
[[Page 38820]]
program priority setting, and policy development, to advance the
mission of the Division of Blood Disorders, NCBDDD and CDC; (2)
develops goals, objectives, and budget; monitors progress and
allocation of resources, and reports accomplishments, future
directions, and resource requirements; (3) facilitates scientific,
policy and program collaboration among divisions and centers, and
between CDC and other Federal/non-Federal partners; (4) promotes
advancement of science throughout the division, supports program
evaluation, and ensures that research meets the highest standards in
the field; (5) provides medical expertise and consultation to planning,
projects, policies and program activities; (6) advises the Office of
the Director of NCBDDD on matters relating to prevention of
complications due to blood disorders and coordinates division responses
to requests for technical assistance or information on activities
supported by the division; (7) develops and produces communications
tools and public affairs strategies to meet the needs of division
programs and mission; (8) represents the division at official
professional and scientific meetings, both within and outside of CDC;
(9) applies evaluation and prevention effectiveness functions in the
assessment of blood disorder programs, projects and activities; (10)
develops, implements and evaluates long term plans for surveillance,
research and prevention activities pertaining to blood disorders; and
(11) drafts and disseminates reports of future plans and needs to
inform policy.
After the Office of the Director (CUBD1) Division of Blood
Disorders, National Center on Birth Defects and Developmental
Disabilities, Office of Noncommunicable Diseases, Injury and
Environmental Health, Centers for Disease Control and Prevention,
insert the following:
Epidemiology and Surveillance Branch (CUBDB). (1) Provides
scientific leadership in the design and implementation of monitoring
systems as well as designs and conducts epidemiologic and genetic
research to identify causes, risk factors and complications of blood
disorders in affected populations; (2) designs and manages surveillance
systems to evaluate the incidence, morbidity, and mortality associated
with blood diseases and disorders; (3) plans, develops and coordinates
special surveys and populations studies to monitor and assess the
complications of blood disorders; (4) designs and implements studies
using surveillance data to identify risk factors for the complications
of blood disorders, and evaluates the effectiveness of the prevention
activities; (5) provides epidemiologic and medical consultation and
technical assistance, including epidemic aids to State and local health
departments, other governmental agencies, and other public and private
institutions in the investigation of blood disorders and related
complications; (6) designs and implements studies to evaluate the
effectiveness of implemented prevention strategies in the treatment
centers; (7) works closely with internal and external organizations in
applying prevalence and incidence data to target and evaluate programs
to prevent the complications of blood diseases and chronic hereditary
disorders; (8) publishes findings and advances arising out of
surveillance and epidemiologic research to the scientific and public
health communities; (9) provides training services to States,
localities, and other countries in investigation, diagnosis,
prevention, and control of blood diseases and chronic hereditary
disorders; (10) assists in designing, implementing, and evaluating
prevention and counseling programs for persons and their families with
chronic blood diseases and selected chronic hereditary disorders; (11)
designs, implements and coordinates the prevention and surveillance
activities of specialized Federally funded prevention centers organized
to prevent the complications of blood diseases and chronic hereditary
disorders; (12) conducts and supports both qualitative and quantitative
research to expand the knowledge base related to blood disorders across
the lifespan; and (13) collaborates with laboratory research branch and
prevention research branch and incorporates the findings of these
branches' activities which leads to prevention of complications of
blood disorders.
Laboratory Research Branch (CUBDC). (1) Identifies new genetic
markers of risk factors and clotting defects for affected groups; (2)
provides reference laboratory diagnosis for multi-site epidemiologic
and surveillance studies; (3) develops techniques and interpretation
methods to improve molecular and coagulation diagnosis; (4) provides
diagnostic support for epidemiologic studies and epidemic aids on
emerging blood disorders and chronic hereditary disorders; (5)
determines the mechanisms of pathogenesis and complications of blood
disorders and chronic hereditary disorders; (6) conducts research and
provides reference services on diagnostic techniques for blood
disorders and chronic hereditary disorders; (7) conducts research to
improve laboratory methodologies and materials; (8) where appropriate,
maintains the national reference laboratory for blood disorders and
chronic hereditary disorders; (9) works closely with entities and
organizations within the agency and organizations external to the
agency to provide laboratory services in support of projects whose
primary aim is to prevent and reduce complications associated with
blood disorders and chronic hereditary disorders; and (10) publishes
findings and advances arising out of surveillance and epidemiologic
research to the scientific and public health communities.
Prevention Research and Informatics Branch (CUBDD). (1) Performs
health services research; (2) translates and evaluates the latest
scientific advances from surveillance, epidemiology and laboratory
support into enhanced delivery of care, prevention services, and
information for affected populations; (3) develops, implements,
evaluates and disseminates education and communication interventions
that seek to identify and educate affected populations, providers and
the public on health risks, protective factors and measures of
effectiveness of health promotion activities and prevention of
complications related to blood disorders; (4) collects, analyzes and
prepares reports to document the prevalence and incidence of blood
disorders and related complications and provides this information to
affected populations through reports, publications, and public access
data sets; (5) supports public health analysis to include facilitating
data collection, data management, data manipulation, analysis, project
reporting and presentation; (6) coordinates partnership activities; (7)
assesses informatics needs and develops strategies to ensure accurate
collection of data related to blood disorders and the division's
activities; (8) conducts applied research to develop, evaluate, improve
and standardize public information systems and educational modules
which support the prevention of complications from blood disorders; (9)
develops and maintains systems for collection, processing, validation,
storage and dissemination of the highest quality information to study
and monitor blood disorders; (10) disseminates findings and advances
arising out of surveillance and epidemiologic research to the
scientific and public health communities, and the
[[Page 38821]]
general public; (11) collaborates with and provides technical
assistance, consultation, and training to local, State, Federal, and
international agencies, universities and governmental and non-
governmental organizations on blood disorders and health related
issues; (12) collaborates with local, State, Federal, and international
agencies, and appropriate governmental and non-governmental
organizations to develop, review, and implement policies that advance
the health of people with blood disorders across the lifespan; (13)
collaborates with funded non-governmental agencies to disseminate best
practices, identify areas of need, facilitate development and
distribution of educational materials, and provide informational
resources to States and affected populations and their caregivers; and
(14) develops informatics related trainings and communicates
informatics changes to external partners.
Dated: June 21, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-16101 Filed 7-2-10; 8:45 am]
BILLING CODE 4160-18-M
